Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and […]
Tag: Evogene
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
REHOVOT, Israel, Aug. 23, 2024 /PRNewswire/ — Evogene Ltd. (“Evogene” or the “Company”) (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development utilizing cutting-edge computational biology technologies […]







